 | • レポートコード：QYR2104Z4714 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、心的外傷後ストレス障害（PTSD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（認知療法、暴露療法、眼球運動脱感作＆再処理（EMDR）、抗うつ薬、抗不安薬、プラゾシン）、用途別市場規模（子供、大人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・心的外傷後ストレス障害（PTSD）の市場動向 ・企業の競争状況、市場シェア ・心的外傷後ストレス障害（PTSD）の種類別市場規模（認知療法、暴露療法、眼球運動脱感作＆再処理（EMDR）、抗うつ薬、抗不安薬、プラゾシン） ・心的外傷後ストレス障害（PTSD）の用途別市場規模（子供、大人） ・心的外傷後ストレス障害（PTSD）の北米市場規模2016-2027（アメリカ、カナダ） ・心的外傷後ストレス障害（PTSD）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・心的外傷後ストレス障害（PTSD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心的外傷後ストレス障害（PTSD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・心的外傷後ストレス障害（PTSD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline (UK)、Pfizer (US)、Eli Lilly and Company (US)、Lundbeck A/S (Denmark)、Azevan Pharmaceuticals (US)、Marinus Pharmaceuticals, Inc. (US)、Tonix Pharmaceuticals Holding Corp. (US)、Bionomics (Australia)、Greenstone LLC (US)、Mylan NV (US)、Otsuka Pharmaceutical (Japan)、Prometheon Pharma (USA)、Ligand Pharma (USA)、Valenta Pharm (Russia)、Lycera Corp (US)、Archimedes (UK)、GMP Endotherapeutics (USA)、Nuvo Pharmaceuticals (Canada)、Beijing Wansheng Pharmaceutical、Zhejiang Huahai Pharmaceutical、Zhejiang Jianfeng Pharmaceutical） ・結論 |
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
Market Analysis and Insights: Global Post-Traumatic Stress Disorder (PTSD) Market
The global Post-Traumatic Stress Disorder (PTSD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder (PTSD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder (PTSD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder (PTSD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder (PTSD) market.
Global Post-Traumatic Stress Disorder (PTSD) Scope and Market Size
Post-Traumatic Stress Disorder (PTSD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder (PTSD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cognitive Therapy
Exposure Therapy
Eye Movement Desensitization And Reprocessing (EMDR)
Antidepressants
Anti-Anxiety Medications
Prazosin
Segment by Application
Children
Adult
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline (UK)
Pfizer (US)
Eli Lilly and Company (US)
Lundbeck A/S (Denmark)
Azevan Pharmaceuticals (US)
Marinus Pharmaceuticals, Inc. (US)
Tonix Pharmaceuticals Holding Corp. (US)
Bionomics (Australia)
Greenstone LLC (US)
Mylan NV (US)
Otsuka Pharmaceutical (Japan)
Prometheon Pharma (USA)
Ligand Pharma (USA)
Valenta Pharm (Russia)
Lycera Corp (US)
Archimedes (UK)
GMP Endotherapeutics (USA)
Nuvo Pharmaceuticals (Canada)
Beijing Wansheng Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cognitive Therapy
1.2.3 Exposure Therapy
1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)
1.2.5 Antidepressants
1.2.6 Anti-Anxiety Medications
1.2.7 Prazosin
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2016-2027)
2.2 Post-Traumatic Stress Disorder (PTSD) Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder (PTSD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Share by Regions (2016-2021)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Regions (2022-2027)
2.3 Post-Traumatic Stress Disorder (PTSD) Industry Dynamic
2.3.1 Post-Traumatic Stress Disorder (PTSD) Market Trends
2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers
2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges
2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2016-2021)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2016-2021)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue
3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2020
3.5 Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2016-2021)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2022-2027)
5 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2016-2021)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2016-2027)
6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type
6.2.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021)
6.2.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027)
6.2.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2027)
6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application
6.3.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021)
6.3.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027)
6.3.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2027)
6.4 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country
6.4.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021)
6.4.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2016-2027)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type
7.2.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021)
7.2.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027)
7.2.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2027)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application
7.3.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021)
7.3.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027)
7.3.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2027)
7.4 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country
7.4.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021)
7.4.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2016-2027)
8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type
8.2.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application
8.3.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region
8.4.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2016-2027)
9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type
9.2.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021)
9.2.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027)
9.2.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2027)
9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application
9.3.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021)
9.3.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027)
9.3.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2027)
9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country
9.4.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021)
9.4.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2016-2027)
10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type
10.2.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application
10.3.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country
10.4.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Details
11.1.2 GlaxoSmithKline (UK) Business Overview
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.1.5 GlaxoSmithKline (UK) Recent Development
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Details
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.2.5 Pfizer (US) Recent Development
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Details
11.3.2 Eli Lilly and Company (US) Business Overview
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.3.5 Eli Lilly and Company (US) Recent Development
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Details
11.4.2 Lundbeck A/S (Denmark) Business Overview
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction
11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.4.5 Lundbeck A/S (Denmark) Recent Development
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Details
11.5.2 Azevan Pharmaceuticals (US) Business Overview
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.5.5 Azevan Pharmaceuticals (US) Recent Development
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Details
11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Development
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Details
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Development
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Details
11.8.2 Bionomics (Australia) Business Overview
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.8.5 Bionomics (Australia) Recent Development
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Details
11.9.2 Greenstone LLC (US) Business Overview
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.9.5 Greenstone LLC (US) Recent Development
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Details
11.10.2 Mylan NV (US) Business Overview
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.10.5 Mylan NV (US) Recent Development
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Details
11.11.2 Otsuka Pharmaceutical (Japan) Business Overview
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction
11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.11.5 Otsuka Pharmaceutical (Japan) Recent Development
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Details
11.12.2 Prometheon Pharma (USA) Business Overview
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.12.5 Prometheon Pharma (USA) Recent Development
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Details
11.13.2 Ligand Pharma (USA) Business Overview
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.13.5 Ligand Pharma (USA) Recent Development
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Details
11.14.2 Valenta Pharm (Russia) Business Overview
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.14.5 Valenta Pharm (Russia) Recent Development
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Details
11.15.2 Lycera Corp (US) Business Overview
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.15.5 Lycera Corp (US) Recent Development
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Details
11.16.2 Archimedes (UK) Business Overview
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.16.5 Archimedes (UK) Recent Development
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Details
11.17.2 GMP Endotherapeutics (USA) Business Overview
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.17.5 GMP Endotherapeutics (USA) Recent Development
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Details
11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction
11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.18.5 Nuvo Pharmaceuticals (Canada) Recent Development
11.18 Beijing Wansheng Pharmaceutical
.1 Beijing Wansheng Pharmaceutical Company Details
.2 Beijing Wansheng Pharmaceutical Business Overview
.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
.5 Beijing Wansheng Pharmaceutical Recent Development
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Details
11.20.2 Zhejiang Huahai Pharmaceutical Business Overview
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.20.5 Zhejiang Huahai Pharmaceutical Recent Development
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Details
11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cognitive Therapy
Table 3. Key Players of Exposure Therapy
Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)
Table 5. Key Players of Antidepressants
Table 6. Key Players of Anti-Anxiety Medications
Table 7. Key Players of Prazosin
Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Regions (2016-2021)
Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Regions (2022-2027)
Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends
Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers
Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges
Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints
Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players (2016-2021)
Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2020)
Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
Table 25. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2016-2021)
Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2016-2021)
Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2022-2027) & (US$ Million)
Table 65. GlaxoSmithKline (UK) Company Details
Table 66. GlaxoSmithKline (UK) Business Overview
Table 67. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product
Table 68. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 69. GlaxoSmithKline (UK) Recent Development
Table 70. Pfizer (US) Company Details
Table 71. Pfizer (US) Business Overview
Table 72. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 73. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 74. Pfizer (US) Recent Development
Table 75. Eli Lilly and Company (US) Company Details
Table 76. Eli Lilly and Company (US) Business Overview
Table 77. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 78. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 79. Eli Lilly and Company (US) Recent Development
Table 80. Lundbeck A/S (Denmark) Company Details
Table 81. Lundbeck A/S (Denmark) Business Overview
Table 82. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product
Table 83. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 84. Lundbeck A/S (Denmark) Recent Development
Table 85. Azevan Pharmaceuticals (US) Company Details
Table 86. Azevan Pharmaceuticals (US) Business Overview
Table 87. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 88. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 89. Azevan Pharmaceuticals (US) Recent Development
Table 90. Marinus Pharmaceuticals, Inc. (US) Company Details
Table 91. Marinus Pharmaceuticals, Inc. (US) Business Overview
Table 92. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 93. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 94. Marinus Pharmaceuticals, Inc. (US) Recent Development
Table 95. Tonix Pharmaceuticals Holding Corp. (US) Company Details
Table 96. Tonix Pharmaceuticals Holding Corp. (US) Business Overview
Table 97. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 98. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 99. Tonix Pharmaceuticals Holding Corp. (US) Recent Development
Table 100. Bionomics (Australia) Company Details
Table 101. Bionomics (Australia) Business Overview
Table 102. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 103. Bionomics (Australia) Recent Development
Table 104. Greenstone LLC (US) Company Details
Table 105. Greenstone LLC (US) Business Overview
Table 106. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 107. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 108. Greenstone LLC (US) Recent Development
Table 109. Mylan NV (US) Company Details
Table 110. Mylan NV (US) Business Overview
Table 111. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 112. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 113. Mylan NV (US) Recent Development
Table 114. Otsuka Pharmaceutical (Japan) Company Details
Table 115. Otsuka Pharmaceutical (Japan) Business Overview
Table 116. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product
Table 117. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 118. Otsuka Pharmaceutical (Japan) Recent Development
Table 119. Prometheon Pharma (USA) Company Details
Table 120. Prometheon Pharma (USA) Business Overview
Table 121. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
Table 122. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 123. Prometheon Pharma (USA) Recent Development
Table 124. Ligand Pharma (USA) Company Details
Table 125. Ligand Pharma (USA) Business Overview
Table 126. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
Table 127. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 128. Ligand Pharma (USA) Recent Development
Table 129. Valenta Pharm (Russia) Company Details
Table 130. Valenta Pharm (Russia) Business Overview
Table 131. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product
Table 132. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 133. Valenta Pharm (Russia) Recent Development
Table 134. Lycera Corp (US) Company Details
Table 135. Lycera Corp (US) Business Overview
Table 136. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 137. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 138. Lycera Corp (US) Recent Development
Table 139. Archimedes (UK) Company Details
Table 140. Archimedes (UK) Business Overview
Table 141. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product
Table 142. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 143. Archimedes (UK) Recent Development
Table 144. GMP Endotherapeutics (USA) Company Details
Table 145. GMP Endotherapeutics (USA) Business Overview
Table 146. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product
Table 147. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 148. GMP Endotherapeutics (USA) Recent Development
Table 149. Nuvo Pharmaceuticals (Canada) Company Details
Table 150. Nuvo Pharmaceuticals (Canada) Business Overview
Table 151. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product
Table 152. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 153. Nuvo Pharmaceuticals (Canada) Recent Development
Table 154. Beijing Wansheng Pharmaceutical Company Details
Table 155. Beijing Wansheng Pharmaceutical Business Overview
Table 156. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
Table 157. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 158. Beijing Wansheng Pharmaceutical Recent Development
Table 159. Zhejiang Huahai Pharmaceutical Company Details
Table 160. Zhejiang Huahai Pharmaceutical Business Overview
Table 161. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
Table 162. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 163. Zhejiang Huahai Pharmaceutical Recent Development
Table 164. Zhejiang Jianfeng Pharmaceutical Company Details
Table 165. Zhejiang Jianfeng Pharmaceutical Business Overview
Table 166. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
Table 167. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021) & (US$ Million)
Table 168. Zhejiang Jianfeng Pharmaceutical Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2020 VS 2027
Figure 2. Cognitive Therapy Features
Figure 3. Exposure Therapy Features
Figure 4. Eye Movement Desensitization And Reprocessing (EMDR) Features
Figure 5. Antidepressants Features
Figure 6. Anti-Anxiety Medications Features
Figure 7. Prazosin Features
Figure 8. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2020 VS 2027
Figure 9. Children Case Studies
Figure 10. Adult Case Studies
Figure 11. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
Figure 12. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Regions: 2020 VS 2027
Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Regions (2022-2027)
Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2020
Figure 17. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2020
Figure 19. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2016-2021)
Figure 20. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2022-2027)
Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2016-2027)
Figure 23. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2016-2027)
Figure 24. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2016-2027)
Figure 25. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2016-2027)
Figure 29. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2016-2027)
Figure 30. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2016-2027)
Figure 31. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2016-2027)
Figure 41. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2016-2027)
Figure 49. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2016-2027)
Figure 50. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2016-2027)
Figure 51. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2016-2027)
Figure 57. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 61. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 62. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 63. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 64. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 65. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 66. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 67. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 68. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 69. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 70. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 71. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 72. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 73. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 74. Lycera Corp (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 75. Archimedes (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 76. GMP Endotherapeutics (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 77. Nuvo Pharmaceuticals (Canada) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 78. Beijing Wansheng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 79. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 80. Zhejiang Jianfeng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…- 世界の心的外傷後ストレス障害（PTSD）市場規模・現状・予測（2021年-2027年） Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened…
- 世界の全般性不安障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global General Anxiety Disorder Therapeutics Market The global General Anxiety Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の認知症・運動障害治療市場規模・現状・予測（2021年-2027年） Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…
- 世界の睡眠運動障害治療薬市場規模・現状・予測（2021年-2027年） Sleep movement disorders are the disorders disrupting during sleep and generally have undesirable verbal or physical behaviors which frequently result in insomnia and daytime fatigue. Movements during sleep are very common, especially among children. Market Analysis and Insights: Global Sleep Moveme…